Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law
May 2, 2019
Cambridge, MA
Please join us for a lively discussion of key legal updates and best practices for 2019. Specifically, we will address:
- Recent Developments Surrounding Antibody Patenting, Safe Harbor and Obviousness-Type Double Patenting
- The Latest Update on Section 101 Subject Matter Eligibility in the Life Sciences
- “Blocking Patents” and How They May Impact the Application of Secondary Considerations
Speakers:
Nicholas E. Bencivenga
Jeffrey M. Jacobstein
Sara A. Leiman, Ph.D.
Alissa K. Lipton
Jill K. MacAlpine, Ph.D.
Leslie A. McDonell
Sanya Sukduang
Oulu (Lulu) Wang, Ph.D.
Date:
Thursday, May 2, 2019
Agenda:
12:30 - 1:00 p.m.
Registration
1:00 - 4:00 p.m.
Workshop
4:00 - 5:00 p.m.
Reception
Location:
Le Meridien Cambridge-MIT
20 Sidney Street
Cambridge, MA 02139
RSVP: To attend, please contact us to arrange an invitation. Space is limited.
Parking: Complimentary parking is available at the hotel. Please bring your parking ticket with you for validation.
Tags
antibodies, Obviousness-type Double Patenting (OTDP), subject matter eligibility, secondary considerations of non-obviousness
